Focus: Inari Medical is a medical device company specializing in catheter-based technologies for treating venous thromboembolism (VTE), including pulmonary embolism and deep vein thrombosis. The company operates in the niche but high-acuity cardiovascular/respiratory intervention space.
Profile data last refreshed 1h ago · AI intelligence enriched 2w ago
No open roles listed right now. Follow Inari Medical to get notified when they start hiring — the background below is worth knowing for when they do.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Lead commercial thrombectomy device with multiple ongoing clinical evaluations (FLAME and other PE studies) supporting market expansion.
Help build intelligence for Inari Medical
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Inari Medical's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Flagship DVT treatment device addressing the venous leg of the VTE spectrum with dedicated clinical programs.
Arterial thrombectomy system extending Inari's platform into adjacent acute limb ischemia indication.
No open positions listed yet. Check their careers page directly.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles
Source: USCIS H-1B Employer Data Hub